Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 11, Issue 12, Pages 1219-1236
Publisher
Informa UK Limited
Online
2018-11-20
DOI
10.1080/17512433.2018.1549487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections
- (2018) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients
- (2018) Alessandro Russo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Ceftazidime/avibactam, Meropenem/vaborbactam or both? Clinical and formulary considerations
- (2018) Jason M Pogue et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae
- (2018) Mario Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Management of KPC-producing Klebsiella pneumoniae infections
- (2018) M. Bassetti et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Acinetobacter spp.
- (2018) E. Matuschek et al. CLINICAL MICROBIOLOGY AND INFECTION
- New antibiotics for ventilator-associated pneumonia
- (2018) Matteo Bassetti et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria
- (2018) Lindsay M. Avery et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cefiderocol: a novel siderophore cephalosporin
- (2018) Justin J Choi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ceftolozane/tazobactam: place in therapy
- (2018) Daniele Roberto Giacobbe et al. Expert Review of Anti-Infective Therapy
- Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection
- (2018) Maddalena Giannella et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection
- (2018) Keith S. Kaye et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
- (2018) Paolo Gaibani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
- (2018) Mical Paul et al. LANCET INFECTIOUS DISEASES
- Colistin versus colistin plus meropenem for severe infections
- (2018) Daniele Roberto Giacobbe LANCET INFECTIOUS DISEASES
- Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
- (2018) Antoni Torres et al. LANCET INFECTIOUS DISEASES
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013–2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility
- (2018) Dee Shortridge et al. Microbial Drug Resistance
- Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment
- (2018) Daniele Roberto Giacobbe et al. Scientific Reports
- Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies
- (2017) D. R. Giacobbe et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Combination therapy for extensively-drug resistant gram-negative bacteria
- (2017) Ilias Karaiskos et al. Expert Review of Anti-Infective Therapy
- Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art
- (2017) Alberto Enrico Maraolo et al. Expert Review of Anti-Infective Therapy
- Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy
- (2017) Daniele Roberto Giacobbe et al. INFECTION
- Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis
- (2017) Philipp P. Kohler et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?
- (2017) Federico Pea et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
- (2017) Matthew E. Falagas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Susceptibility of MDR Pseudomonas aeruginosa to ceftolozane/tazobactam and comparison of different susceptibility testing methods
- (2017) Frieder Schaumburg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
- (2017) Helio S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics/pharmacodynamics of systemically administered polymyxin B against Klebsiella pneumoniae in mouse thigh and lung infection models
- (2017) Cornelia B Landersdorfer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
- (2017) Hajo Grundmann et al. LANCET INFECTIOUS DISEASES
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- In VitroActivity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
- (2016) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
- (2016) Deanna J. Buehrle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
- (2016) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Salvage Therapy with Ceftolozane-Tazobactam for Multidrug-Resistant Pseudomonas aeruginosa Infections
- (2016) Juan José Castón et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
- (2016) Florian M. Wagenlehner et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
- (2016) John E. Mazuski et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study
- (2016) D. R. Giacobbe et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In vitropharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms
- (2016) Sherwin K. B. Sy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitrosynergy of colistin combinations against extensively drug-resistantAcinetobacter baumanniiproducing OXA-23 carbapenemase
- (2016) Wenjuan Wei et al. JOURNAL OF CHEMOTHERAPY
- Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
- (2016) Yehuda Carmeli et al. LANCET INFECTIOUS DISEASES
- Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?
- (2016) Valerio Del Bono et al. Virulence
- Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery
- (2016) Antonio Salsano et al. Interactive Cardiovascular and Thoracic Surgery
- Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
- (2015) Cristina García-Salguero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymyxin B in Combination with Antimicrobials LackingIn VitroActivity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
- (2015) Maria Helena Rigatto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins
- (2015) M. Berrazeg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoActivities of Simulated Human Doses of Cefepime and Cefepime-AAI101 against Multidrug-Resistant Gram-Negative Enterobacteriaceae
- (2015) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary:Optimal Usage of Colistin: Are We Any Closer?
- (2015) Jason M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
- (2015) Joseph Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study
- (2015) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections
- (2015) Matteo Bassetti et al. Current Opinion in Critical Care
- Colistin and doripenem combinations againstPseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance
- (2015) Neang S. Ly et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
- (2015) Mario Tumbarello et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Catechol Siderophore Transport by Vibrio cholerae
- (2015) Elizabeth E. Wyckoff et al. JOURNAL OF BACTERIOLOGY
- Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
- (2015) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
- (2015) Florian M Wagenlehner et al. LANCET
- Mutation-Driven β-Lactam Resistance Mechanisms among Contemporary Ceftazidime-Nonsusceptible Pseudomonas aeruginosa Isolates from U.S. Hospitals
- (2014) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
- (2014) Rujipas Sirijatuphat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pseudomonas aeruginosa Ceftolozane-Tazobactam Resistance Development Requires Multiple Mutations Leading to Overexpression and Structural Modification of AmpC
- (2014) Gabriel Cabot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
- (2014) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
- (2014) George L. Daikos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening?
- (2014) D.R. Giacobbe et al. CLINICAL MICROBIOLOGY AND INFECTION
- Eravacycline for the treatment of intra-abdominal infections
- (2014) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
- (2014) Ilias Karaiskos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Combination therapy for carbapenem-resistant Gram-negative bacteria
- (2014) M. Paul et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Ceftaroline-Avibactam Tested Against Contemporary Enterobacteriaceae Isolates Carrying β-Lactamases Prevalent in the United States
- (2014) Mariana Castanheira et al. Microbial Drug Resistance
- Siderophore–drug complexes: potential medicinal applications of the ‘Trojan horse’ strategy
- (2014) Agnieszka Górska et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Proliferation and significance of clinically relevant β-lactamases
- (2013) Karen Bush Annals of the New York Academy of Sciences
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens
- (2013) Ana M. Sandri et al. CLINICAL INFECTIOUS DISEASES
- Screening and deciphering antibiotic resistance inAcinetobacter baumannii: a state of the art
- (2013) Rémy A Bonnin et al. Expert Review of Anti-Infective Therapy
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- Action Plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece
- (2013) Helena C. Maltezou et al. Journal of Global Antimicrobial Resistance
- Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette ChromosomemecTypes
- (2012) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
- (2011) S. M. Garonzik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Affinity of the New Cephalosporin CXA-101 to Penicillin-Binding Proteins of Pseudomonas aeruginosa
- (2010) B. Moya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
- (2009) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started